Naloxone may benefit newborn infants with perinatal asphyxias.
Naloxone may confer benefits to newborn infants with respiratory depression.
Randomised controlled trials may compare an administration of naloxone to newborn infants.
Naloxone can be available for a management of newborn infants.
Randomised controlled trials may evaluate an administration of epinephrine to a newborn infant.